Although cytokines like Interferon alpha (IFN-α) and Interferon gamma (IFN-γ) theoretically bolster the cytotoxicity of T cells against tumors (20), their therapeutic efficacy in clinical trials has been limited (21), indicating that cytokine function can also be dysregulated in the tumor microenvironment. Here, IFNA1 is linked to neoplasm.